Regulation of stem cell self-renewal and differentiation by Wnt and Notch are conserved throughout the adenoma-carcinoma sequence in the colon
- Pramudita Ramadhina Prasetyanti†1,
- Cheryl Doreen Zimberlin†1,
- Michael Bots1,
- Louis Vermeulen1, 2,
- Felipe De Sousa E Melo1 and
- Jan Paul Medema1Email author
© Prasetyanti et al.; licensee BioMed Central Ltd. 2013
Received: 29 July 2013
Accepted: 24 September 2013
Published: 21 October 2013
Colon cancer stem cells are shown to be the self-renewing cells within a tumor that give rise to all lineages of more differentiated tumor cells. In this respect they are remarkably similar to their non-malignant counterparts that orchestrate the intestinal lining. This suggests that, despite the numerous genetic aberrations and morphological changes that have occurred during cancer initiation and progression, a remnant homeostatic regulation persists.
Using a number of human and mouse intestinal-derived organoid cultures from normal, adenoma and cancerous tissues, we show here that Notch signals coordinate self-renewal and lineage determination not only in normal, but also at the adenoma and carcinoma stage in both mice and humans. Moreover, the Wnt pathway, which carries activating mutations in virtually all colon cancers, is not as previously predicted constitutively active in adenomas and carcinomas, but still displays a heterogeneous activity pattern that determined stemness in all stages of disease.
These data for the first time provide a comprehensive overview of Wnt and Notch-mediated signaling in the different stages of the adenoma-carcinoma sequence and demonstrates that these morphogenic pathways, despite mutations, remain crucial determinants of both architecture and hierarchy in normal and malignant intestinal tissue.
KeywordsColorectal cancer Wnt Notch Stem cells Adenoma Morphogenic pathways Organoid cultures
Normal gut homeostasis is ensured by intestinal stem cells (ISCs), which rely on integration of various morphogenic pathways including bone morphogenetic protein, Hedgehog, Notch and Wnt signaling cascades . Colorectal cancer (CRC) is a multistep process in which genetic hits induce transition from normal mucosa via adenomatous lesions to an invasive carcinoma . Adenoma initiation is suggested to occur via deregulation of these morphogenic pathways. First and foremost, mutations leading to activation of the Wnt cascade are seen in all CRC patients [1, 3]. However, these activating mutations never result in a complete activation, but rather in a finely-tuned Wnt activity level . Furthermore, cell-to-cell variation in pathways activity is frequently observed. In agreement with these concepts are our recent observations that have pinpointed Wnt pathway regulation as the basis of cancer stemness in CRC . Functionally marked by high Wnt pathway activity, colon cancer stem cells (CSCs) have self-renewal capacity and the potential to differentiate into all cell lineages present in cancerous tissue . These similarities between ISCs and CSCs may therefore point to the intriguing possibility that the response to morphogenic signals is not lost during tumorigenesis. Despite the wealth of data regarding the role of morphogenic pathways in controlling cell fate and proliferation in intestinal tissue, to our surprise few studies have attempted to comprehensively assess their role throughout the stages of neoplastic progression. For example, whereas Notch inhibition leads to goblet cells accumulation in adenomas , little is known on the role of Wnt signaling in this stage.
Using a number of human and mouse intestinal-derived organoid cultures from normal, adenoma and cancerous tissues [8, 9], we provide a comprehensive overview on the role of both Wnt and Notch morphogenic pathways in the different stages of CRC development. We find that Notch inhibition decreases stemness and enhances goblet-like differentiation in all stages of disease. Conversely, Wnt activity is associated with stemness in normal, adenoma and carcinoma tissue. Our results point to the conclusion that colon carcinogenesis, at early and late stages consistently retain numerous characteristics of the normal intestine.
Previous studies have highlighted the role of Wnt and/or Notch in distinct stages of colon cancer. For instance, Notch inhibition has been shown to induce goblet differentiation in mouse adenomas and block stemness in colon CSCs [7, 14]. Similarly, we have previously shown that Wnt activity determines stemness in adenocarcinoma-derived colon CSCs. This present study, however, for the first time provides a comprehensive overview of these pathways at all stages and extends these surprising findings by showing that Wnt pathway heterogeneity persists at all stages despite evident mutations in the Wnt pathway and that Notch signals maintain a balance between self-renewal and cell lineage decisions. Currently, the molecular mechanisms underlying such heterogeneity remain unclear. Nevertheless, the organization appears to be purely intrinsic to epithelial cells as the mesenchymal niche is not present in vitro. Differential Wnt activity in the normal epithelial organoid cultures was suggested to exist due to the presence of Wnt/Notch ligand producing paneth cells . Likewise, tuning of Wnt signaling in adenoma or adenocarcinoma might be achieved by a similar mechanism. In this respect, it is interesting to note that paneth-like cells have been reported in mouse adenomas and reside in close proximity to the LGR5+ adenoma stem cells . Furthermore, microenvironment derived signals such as HGF and Jagged-1 [5, 16] could also be responsible for this Wnt hierarchy.
Materials and methods
Murine tissue culture
The Animal Experimental Committee (DEC) of the Academic Medical Center (AMC) approved all animal experiments. Normal crypt (C57B7/6) and adenoma cultures (Lgr5-EGFP-IRES-creERT2/APCflox/flox) mice cultures were generated and maintained as previously described by  and  respectively.
Human tissue culture
Human tissues were obtained in accordance with the legislation in the Netherlands and approved by the medical ethical committee in the AMC. Human crypt, adenoma and carcinoma cultures were generated and maintained as previously described [9, 18].
Dibenzazepine treatment and clonogenicity assays
For clonogenic assays 150 crypts and 5000 adenoma calls were plated per well in triplicate and outgrowth was measured after 3 days and 7 days respectively of 10 μM dibenzazepine (DBZ) (Merck) treatment. For statistical analysis two-tailed t-tests were applied. Clonogenicity for adenocarcinomas was determined in a limiting dilution fashion at 1, 2, 4, 8, 16, 32, 64 and 128 cells per well in a ultra-low adherent 96 well plate (Corning) after 10 μM DBZ treatment. Results were statistically evaluated using the R software package (http://bioinf.wehi.edu.au/software/elda/index.html).
Organoid transductions, as in , were performed using TCF/LEF reporter driving expression of GFP (TOP-GFP) was a gift from Laurie Ailles. For clonogenicity assays, 5000 cells were sorted (FACSAria, BD) TOP-GFPhigh and TOP-GFPlow.
Total RNA was extracted using the RNeasy kit (Qiagen) and cDNA was synthesized using SuperScript® III reverse transcriptase (Life Technologies) with random primers (Invitrogen) using 2xSYBR Green Master Mix (Roche) for RT-qPCR measurement. For primers see Additional file 4.
Immunohistochemistry and immunofluorescence
Immunohistochemistry stainings were analyzed in formalin-fixed, paraffin-embedded tissues and analyzed using standard techniques. 8-chamber culture slides (BD) were used for whole mount immunofluorescent stainings. Images were taken on a Leica TCS-SP2. For antibodies see Additional file 4.
Intestinal stem cells
Cancer stem cell
Epithelial cell adhesion molecule
Intestinal stem cells
JPM is supported by a VICI grant of NWO. PRP and JPM are supported by Dutch Cancer Society grant UvA 2009–4416. MB and LV are supported by Dutch Cancer Society Fellowships.
- Medema JP, Vermeulen L: Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature. 2011, 474: 318-326.View ArticlePubMedGoogle Scholar
- Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell. 1990, 61: 759-767.View ArticlePubMedGoogle Scholar
- The Cancer Genome Atlas Network : Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012, 487: 330-337.PubMed CentralView ArticleGoogle Scholar
- Albuquerque C, Breukel C, van der Luijt R, Fidalgo P, Lage P, Slors FJ, Leitão CN, Fodde R, Smits R: The “just-right” signaling model: APC somatic mutations are selected based on a specific level of activation of the β-catenin signaling cascade. Hum Mol Genet. 2002, 11: 1549-1560.View ArticlePubMedGoogle Scholar
- Vermeulen L, Melo DSE, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, Sprick MR, Kemper K, Richel DJ, Stassi G, Medema JP: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010, 12: 468-476.View ArticlePubMedGoogle Scholar
- Vermeulen L, Todaro M, de Sousa MF, Sprick MR, Kemper K, Perez AM, Richel DJ, Stassi G, Medema JP: Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA. 2008, 105: 13427-13432.PubMed CentralView ArticlePubMedGoogle Scholar
- van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, Cozijnsen M, Robine S, Winton DJ, Radtke F, Clevers H: Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature. 2005, 435: 959-963.View ArticlePubMedGoogle Scholar
- Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange D, van Es JH, Abo A, Kujala P, Peters PJ, Clevers H: Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009, 459: 262-U147.View ArticlePubMedGoogle Scholar
- Sato T, Stange DE, Ferrante M, Vries RG, van Es JH, van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J, Siersema PD, Clevers H: Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology. 2011, 141: 1762-1772.View ArticlePubMedGoogle Scholar
- West AB, Isaac CA, Carboni JM, Morrow JS, Mooseker MS, Barwick KW: Localization of villin, a cytoskeletal protein specific to microvilli, in human ileum and colon and in colonic neoplasms. Gastroenterology. 1988, 94: 343-352.PubMedGoogle Scholar
- Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature. 2007, 445: 111-115.View ArticlePubMedGoogle Scholar
- Kemper K, Prasetyanti PR, De LW, Rodermond H, Clevers H, Medema JP: Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem Cells. 2012, 30: 2378-2386.View ArticlePubMedGoogle Scholar
- Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M, Clevers H: Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science. 2012, 337: 730-735.View ArticlePubMedGoogle Scholar
- Hoey T, Yen WC, Axelrod F, Basi J, Donigian L, Dylla S, Fitch-Bruhns M, Lazetic S, Park IK, Sato A, Satyal S, Wang X, Clarke MF, Lewicki J, Gurney A: DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell. 2009, 5: 168-177.View ArticlePubMedGoogle Scholar
- van Es JH, Jay P, Gregorieff A, van Gijn ME, Jonkheer S, Hatzis P, Thiele A, van den Born M, Begthel H, Brabletz T, Taketo MM, Clevers H: Wnt signalling induces maturation of paneth cells in intestinal crypts. Nat Cell Biol. 2005, 7: 381-U37.View ArticlePubMedGoogle Scholar
- Lu J, Ye X, Fan F, Xia L, Bhattacharya R, Bellister S, Tozzi F, Sceusi E, Zhou Y, Tachibana I, Maru DM, Hawke DH, Rak J, Mani SA, Zweidler-McKay P: Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of jagged-1. Cancer Cell. 2013, 23: 171-185.PubMed CentralView ArticlePubMedGoogle Scholar
- Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ, Clevers H: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 2009, 45: 608-U119.View ArticleGoogle Scholar
- Prasetyanti PR, Zimberlin CD, De Sousa E Melo F, Medema JP: Isolation and propagation of colon cancer stem cells. Methods Mol Biol. 2013, 1035: 247-259.View ArticlePubMedGoogle Scholar
- Koo BK, Stange DE, Sato T, Karthaus W, Farin HF, Huch M, van Es JH, Clevers H: Controlled gene expression in primary Lgr5 organoid cultures. Nat Methods. 2012, 9: 81-83.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.